Browsing Pathways
Showing 81 -
90 of 605359 pathways
SMPDB ID | Pathway Name and Description | Pathway Class | Chemical Compounds | Proteins |
---|---|---|---|---|
SMP0128983View Pathway |
Vosoritide Drug Metabolism |
|
||
SMP0174497View Pathway |
Vortioxetine Predicted Metabolism Pathway newMetabolites of Vortioxetine are predicted with biotransformer.
|
|
||
SMP0129763View Pathway |
Vorsetuzumab mafodotin Drug Metabolism |
|
||
SMP0125454View Pathway |
Voriconazole MetabolismVoriconazole is an triazole antifungal medication used to treat serious, invasive fungal infections. It has increased affinity to 14-alpha sterol demethylase which means it is useful against Fluconazole-resistant organisms. Voriconazole is taken either orally or injected intravenously. The bioavailability of voriconazole is 96%. When taken orally it is transported from the intestine into the intestinal epithelial cell possibly via solute carrier family 15 member 1, one of 3 drug transporters into epithelial cells. It is then transported into blood vessels via ATP-binding cassette sub-family C member 3. It is then transported through the blood to the liver where it is transported in by a liver drug transporter like solute carrier family 22 member 1.
On the endoplasmic reticulum membrane Voriconazole is metabolized into Voriconazole N-Oxide by Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5, or Cytochrome P450 3A7, which makes up 72% of metabolites found. Voriconazole N-Oxide is metabolized into a voriconazole related compound (UK-51,060) by an unknown enzyme. That is predicted by biotransformer to be metabolized by Carbonyl reductase [NADPH] 1 into a similar voriconazole related compound (UK-215,364). That is predicted by biotransformer to be metabolized by UDP-glucuronosyltransferase 1-3 into Voriconazole O-glucuronide derivative (1).
Voriconazole also metabolizes into 4-Hydroxyvoriconazole via the enzymes Cytochrome P450 3A4, Cytochrome P450 3A5, or Cytochrome P450 3A7. 4-Hydroxyvoriconazole is predicted by biotransformer to be metabolized by UDP-glucuronosyltransferase 1-3 into 4-Hydroxyvoriconazole 4-O-glucuronide.
Voriconazole and all the metabolites are transported out of the liver and into blood vessels by a transport protein such as multidrug resistance-associated protein 4. They all then travel to the kidney where they are excreted in the urine. Less than 2% of the dose is excreted as unchanged voriconazole. 72% is excreted as the metabolite voriconazole N-oxide.
|
|
||
SMP0129203View Pathway |
Voretigene neparvovec Drug Metabolism |
|
||
SMP0129772View Pathway |
Vopratelimab Drug Metabolism |
|
||
SMP0130896View Pathway |
Vonoprazan Drug MetabolismVonoprazan is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Vonoprazan passes through the liver and is then excreted from the body mainly through the kidney.
|
|
||
SMP0130163View Pathway |
Vonlerolizumab Drug Metabolism |
|
||
SMP0129114View Pathway |
Vonicog alfa Drug Metabolism |
|
||
SMP0128954View Pathway |
Vonapanitase Drug Metabolism |
|
Showing 81 -
90 of 106736 pathways